Adenosine Signaling, Priapism and Novel Therapies
- 1 March 2009
- journal article
- review article
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 6 (Supplement), 292-301
- https://doi.org/10.1111/j.1743-6109.2008.01187.x
Abstract
Priapism is defined as abnormal prolonged penile erection lasting at least for 4 hours occurring without sexual interest. Forty percent of sickle cell disease (SCD) patients display priapism. The disorder is dangerous and urgent given its association with ischemia-mediated erectile tissue damage and subsequent erectile dysfunction. Current strategies to manage the disorder are poor due to lack of fundamental understanding of the molecular mechanisms of priapism. Adenosine is a signaling nucleoside that elicits many pathophysiological effects by engaging membrane receptors. Recent evidence shows that adenosine may play an important role in priapism via adenosine receptor. To summarize the recent findings on the importance of adenosine signaling in the pathogenesis of priapism. Evidence in the literature on the association between adenosine signaling and the development of priapism. This article reviews the literature that relates to the contributory role of adenosine signaling in priapism in multiple animal models and humans. Excessive adenosine accumulation in the penis, coupled with increased A(2B)R signaling, contributes to priapism in two independent lines of mutant mice. One is adenosine deaminase (ADA)-deficient mice, the only animal displaying spontaneously prolonged penile erection, and the other is SCD transgenic mice, a well-accepted priapic animal model. Both polyethylene glycol-modified ADA (PEG-ADA) enzyme therapy and A(2B)R antagonists are capable of inhibiting potent corpus cavernosal vascular relaxation associated with priapic-like activity seen in both ADA-deficient mice and SCD transgenic mice, indicating that PEG-ADA enzyme therapy is likely to be a novel therapy for such a dangerous urological disorder. Overall, the research reviewed here raises the intriguing possibility that elevated adenosine signaling contributes to priapism in general and that this signaling pathway represents a potentially important therapeutic target for the treatment of priapism.Keywords
This publication has 45 references indexed in Scilit:
- Adenosine Actions are Preserved in Corpus Cavernosum from Obese and Type II Diabetic db/db MouseThe Journal of Sexual Medicine, 2008
- Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signalingJCI Insight, 2008
- Corpus Cavernosum from Men with Vasculogenic Impotence Is Partially Resistant to Adenosine Relaxation due to Endothelial A2BReceptor DysfunctionJournal of Pharmacology and Experimental Therapeutics, 2006
- Pathology of “Berkeley” sickle-cell mice includes gallstones and priapismBlood, 2006
- Cyclic Nucleotide Signaling in Cavernous Smooth MuscleThe Journal of Sexual Medicine, 2005
- Functional adenosine receptors in human corpora cavernosaInternational Journal of Andrology, 2000
- STIMULATION OF P2y PURINOCEPTORS INDUCES, VIA NITRIC OXIDE PRODUCTION, ENDOTHELIUM-DEPENDENT RELAXATION OF HUMAN ISOLATED CORPUS CAVERNOSUMJournal of Urology, 1999
- Identification of an A2a Adenosine Receptor Domain Specifically Responsible for Mediating Short-Term DesensitizationBiochemistry, 1997
- Effects of adenosine analogues on apomorphine-induced penile erection in ratsGeneral Pharmacology: The Vascular System, 1995
- PATHOLOGY OF SICKLE CELL ANEMIASouthern Medical Journal, 1934